Kothari G - Search Results

1

Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach.

Siva S, Kothari G, Muacevic A, Louie AV, Slotman BJ, Teh BS, Lo SS. Siva S, et al. Among authors: kothari g. Nat Rev Urol. 2017 Sep;14(9):549-563. doi: 10.1038/nrurol.2017.87. Epub 2017 Jun 20. Nat Rev Urol. 2017. PMID: 28631740 Review.

2

Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: a systematic review.

Kothari G, Foroudi F, Gill S, Corcoran NM, Siva S. Kothari G, et al. Acta Oncol. 2015 Feb;54(2):148-57. doi: 10.3109/0284186X.2014.939298. Epub 2014 Aug 20. Acta Oncol. 2015. PMID: 25140860 Review.

3

Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases.

Kothari G, Louie AV, Pryor D, Vela I, Lo SS, Teh BS, Siva S. Kothari G, et al. Chin Clin Oncol. 2017 Sep;6(Suppl 2):S17. doi: 10.21037/cco.2017.06.30. Chin Clin Oncol. 2017. PMID: 28917255 Free article. Review.

4

Stereotactic Body Radiotherapy for Primary Prostate Cancer.

Kothari G, Loblaw A, Tree AC, van As NJ, Moghanaki D, Lo SS, Ost P, Siva S. Kothari G, et al. Technol Cancer Res Treat. 2018 Jan 1;17:1533033818789633. doi: 10.1177/1533033818789633. Technol Cancer Res Treat. 2018. PMID: 30064301 Free PMC article.

5

Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer.

Kothari G, Ost P, Cheung P, Blanchard P, Tree AC, van As NJ, Lo SS, Moghanaki D, Loblaw A, Siva S. Kothari G, et al. Curr Oncol Rep. 2019 Mar 27;21(5):43. doi: 10.1007/s11912-019-0791-5. Curr Oncol Rep. 2019. PMID: 30919165 Review.

6

Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies.

Zaorsky NG, Lehrer EJ, Kothari G, Louie AV, Siva S. Zaorsky NG, et al. Among authors: kothari g. Eur Urol Oncol. 2019 Sep;2(5):515-523. doi: 10.1016/j.euo.2019.05.007. Epub 2019 Jul 11. Eur Urol Oncol. 2019. PMID: 31302061

7

A systematic review and meta-analysis of the prognostic value of radiomics based models in non-small cell lung cancer treated with curative radiotherapy.

Kothari G, Korte J, Lehrer EJ, Zaorsky NG, Lazarakis S, Kron T, Hardcastle N, Siva S. Kothari G, et al. Radiother Oncol. 2021 Feb;155:188-203. doi: 10.1016/j.radonc.2020.10.023. Epub 2020 Oct 21. Radiother Oncol. 2021. PMID: 33096167

8

Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial.

Kwan EM, Spain L, Anton A, Gan CL, Garrett L, Chang D, Liow E, Bennett C, Zheng T, Yu J, Dai C, Du P, Jia S, Fettke H, Abou-Seif C, Kothari G, Shaw M, Parente P, Pezaro C, Tran B, Siva S, Azad AA. Kwan EM, et al. Among authors: kothari g. Eur Urol. 2022 Mar;81(3):253-262. doi: 10.1016/j.eururo.2021.08.011. Epub 2021 Sep 4. Eur Urol. 2022. PMID: 34493414 Clinical Trial.

9

Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases.

Siva S, Jones G, Bressel M, Shaw M, Chander S, Chu J, Plumridge N, Byrne K, Kothari G, Hardcastle N, Gaudreault M, Kron T, Wheeler G, MacManus M, Hanna GG, Ball DL, David S. Siva S, et al. Among authors: kothari g. Int J Radiat Oncol Biol Phys. 2022 Dec 1;114(5):862-870. doi: 10.1016/j.ijrobp.2022.05.034. Epub 2022 Jun 22. Int J Radiat Oncol Biol Phys. 2022. PMID: 35752407

10

The impact of inter-observer variation in delineation on robustness of radiomics features in non-small cell lung cancer.

Kothari G, Woon B, Patrick CJ, Korte J, Wee L, Hanna GG, Kron T, Hardcastle N, Siva S. Kothari G, et al. Sci Rep. 2022 Jul 27;12(1):12822. doi: 10.1038/s41598-022-16520-9. Sci Rep. 2022. PMID: 35896707 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page